Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases

Abstract The cannabinoid substances contained in the Cannabis sativa plant have been shown to have great potential in a wide variety of therapeutic applications. However, its neuroprotective capacity has been the most widely studied in diseases such as Alzheimer's, Parkinson's, Huntington's, multiple sclerosis and amyotrophic lateral sclerosis. Knowing the problems of formulating these substances in different dosage forms and their side effects, the present paper addresses different alternatives offered by the use of nanotechnology to transport these drugs in suitable platforms, as well as the different methodologies and materials used for this purpose.